Abstract
Stroke is the third leading cause of death and the leading cause of disability in contemporary society. Aneurysmal subarachnoid hemorrhage (aSAH) is a hemorrhagic stroke which accounts for 7% of all stroke cases and 22 to 25% of cerebrovascular deaths. Aneurysmal subarachnoid hemorrhage is a very complex disease and many controversies on its pathophysiology and management have not yet been settled. The aim of this review is to present the most recent evidence-based advances in the pathophysiology and perioperative management of aSAH.
Original language | English (US) |
---|---|
Pages (from-to) | 5792-5808 |
Number of pages | 17 |
Journal | Current Pharmaceutical Design |
Volume | 19 |
Issue number | 32 |
DOIs | |
State | Published - Oct 1 2013 |
Keywords
- Delayed neurologic deficits
- Stroke
- Subarachnoid hemorrhage
- Vasospasm
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery